Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CIB IFRS Consolidated Financial Statements FY25

10th Feb 2026 07:00

RNS Number : 3239S
Commercial Intnl Bank (Egypt) SAE
10 February 2026
 
http://www.rns-pdf.londonstockexchange.com/rns/3239S_1-2026-2-9.pdf

 

Consolidated Income Statement for the Year Ended December 31, 2025

 

Notes

Dec. 31, 2025

 

Dec. 31, 2024

 

 

 

 

 

Interest revenue calculated using the effective interest method other interest and similar income

211,600,177

 

182,735,474

Interest expense calculated using the effective interest method other interest and similar expense

 

(104,121,746)

(91,751,450)

Net interest income

3

107,478,431

 

 

90,984,024

 

 

 

Fee and commission income

16,036,009

 

12,813,876

Fee and commission expense

 

(6,816,966)

(5,728,656)

Net fee and commission income

4

9,219,043

 

 

7,085,220

 

 

 

Dividend income

5

216,273

 

195,047

Net trading income

6

1,523,649

 

20,470,230

Gain on investments

21

775,841

 

459,337

Administrative expenses

7

(24,692,107)

 

(19,952,958)

Other operating income (expenses)

8

(1,533,040)

 

(22,323,778)

Net impairment Released (charge)

9

11,804,786

 

(5,401,308)

Bank's share in the profit and (loss) of associates

12

10,512

(17,786)

Profit before income tax from continuing operations

 

104,803,388

71,498,028

 

 

 

Income tax expense

10

(29,323,206)

 

(21,878,946)

 

 

 

Net profit for the year

 

75,480,182

49,619,082

 

 

 

Attributable to:

 

 

 

Equity holders of the parent

75,460,219

 

49,558,744

Non-controlling interest

 

19,963

 

 

60,338

Net profit for the year

 

75,480,182

 

 

49,619,082

 

 

 

 

 

 

 

Earnings per shareEquity shareholders of the parent for the year:

11

 

 

Basic earnings per share

22.34

 

14.67

Diluted earnings per share

22.10

 

14.51

 

The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements.

 

Refer note 45 for changes to comparative figures.

 

Islam Zekry

 

Hisham Ezz Al-Arab

Group CFO & Executive Board Member

 

CEO & Executive Board Member

9-Feb-2026

9-Feb-2026

 

 

Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2025

 

Dec. 31, 2025

 

Dec. 31, 2024

 

 

Profit for the year

 

75,480,182

49,619,082

 

 

 

Other comprehensive income that will not be reclassified to the income statement:

 

 

 

Change in fair value of equity instruments measured at fair value through comprehensive income

503,643

 

473,294

Deferred Tax impact for investments that will not be reclassified to P&L

(96,248)

 

(15,674)

Other comprehensive income that will be reclassified to the income statement:

 

 

 

Change in fair value of financial assets measured at fair value through comprehensive income

10,758,425

 

9,242,129

Reclassification to consolidated income statement

(498,433)

 

(459,337)

Cumulative foreign currencies translation differences

(295,691)

 

989,367

Deferred Tax impact for investments that may be reclassified to P&L

(615,506)

 

(654,214)

Effect of ECL in fair value of debt instruments measured at fair value through OCI

(40,145)

 

 

936,949

Total comprehensive income for the year, net of tax

85,196,227

 

 

60,131,596

 

 

 

Attributable to:

 

 

 

Equity holders of the parent

85,062,367

 

60,071,258

Non-controlling interest

133,860

 

 

60,338

Total comprehensive income for the year, net of tax

85,196,227

 

 

60,131,596

 

Consolidated Statement of Financial Position as at December 31, 2025

 

 

Notes

Dec. 31, 2025

 

Dec. 31, 2024

 

 

 

 

 

Assets

 

 

 

 

Cash and cash equivalents

13

20,002,406

 

21,752,997

 

Balances at the central bank

14

68,874,046

 

114,778,023

 

Due from banks

15

135,236,549

 

270,829,834

 

Loans and advances to banks, net

16

34,440,770

 

9,555,410

 

Loans and advances to customers, net

17

507,953,766

 

343,542,674

 

Financial Assets at fair value through profit or loss

20

3,173,539

 

380,769

 

Derivative financial instruments

18

620,349

 

819,711

 

Financial Assets at fair value through Other comprehensive income

20

373,747,694

 

234,694,966

 

Financial Assets at amortized cost

20

236,672,175

 

168,118,219

 

Right of use assets

24

2,469,076

 

1,301,850

 

Investments in associates

22

45,210

 

98,193

 

Non-current-assets held for sale

43

182,827

 

-

 

Other assets

23

54,040,912

 

44,282,773

 

Deferred tax assets

10.2

2,545,498

 

2,685,330

 

Property and equipment

24

5,481,682

3,997,929

 

Total assets

 

1,445,486,499

 

1,216,838,678

 

 

Liabilities and equity

 

 

 

 

Liabilities

 

 

 

 

Due to banks

25

3,353,746

 

2,034,885

 

Due to customers

26

1,110,395,693

 

972,595,958

 

Lease liabilities

24

2,526,481

 

1,425,604

 

Derivative financial instruments

18

137,802

 

100,571

 

Non-current-liabilities held for sale

44

53,860

 

1,397

 

Issued debt instruments

19

4,761,558

 

5,067,781

 

Other liabilities

28

33,144,838

 

27,725,569

 

Current Tax liability

20,570,313

 

18,327,968

 

Other loans

27

30,471,499

 

23,962,389

 

Provisions

29

15,644,651

18,623,634

 

Total liabilities

 

1,221,060,441

1,069,865,756

 

 

Equity attributable to equity holders of parent

 

 

 

 

Issued and paid in capital

30

33,779,361

 

30,431,580

 

Reserves

31

105,020,603

 

62,899,966

 

Reserve for employee stock ownership plan (ESOP)

31.9

2,343,532

 

1,868,235

 

Retained earnings

31.8

83,254,686

51,590,097

 

Total equity attributable to equity holders of the parent

 

224,398,182

146,789,878

 

 

Total equity attributable to non-controlling interest

39

27,876

 

183,044

 

Total equity

224,426,058

146,972,922

 

 

Total liabilities and equity

1,445,486,499

1,216,838,678

 

 

 

 

The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements.

 

 

 

 

Islam Zekry

 

Hisham Ezz Al-Arab

 

 

Group CFO & Executive Board Member

 

CEO & Executive Board Member

 

 

9-Feb-2026

9-Feb-2026

 

 

Consolidated statement of changes in equity for the year ended December 31, 2025

 

Dec. 31, 2025

Issued and paid-up capital

Legal reserve

General reserve

General risk reserve

Special reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders' Equity

Non-controlling interests

Total

 

Beginning balance

30,431,580

6,208,674

62,422,792

1,550,906

-

(670,972)

22,818

(7,789,896)

17,924

51,590,097

1,868,235

1,137,720

146,789,878

183,044

146,972,922

Total comprehensive income net of tax:

 

 

 

Net profit of the year

-

-

-

-

-

-

-

-

-

75,460,219

-

-

75,460,219

19,963

75,480,182

Transferred to general risk reserve

-

-

-

26,186

-

-

-

-

-

(26,186)

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

-

-

9,937,984

-

-

-

-

9,937,984

113,897

10,051,881

Transferred (from) to banking risk reserve

 

-

-

-

-

-

-

-

-

(2,628)

2,628

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

-

-

-

-

-

-

-

(40,145)

-

-

-

-

(40,145)

-

(40,145)

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

-

(295,691)

(295,691)

-

(295,691)

Total comprehensive income

-

-

-

26,186

-

-

-

9,897,839

(2,628)

75,436,661

-

(295,691)

85,062,367

133,860

85,196,227

Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI

 

-

-

-

-

-

-

-

(111,370)

-

111,370

-

-

-

-

-

Transferred to reserves

 

-

2,771,284

19,758,610

-

-

-

2,246

-

-

(21,744,828)

(787,312)

-

-

-

-

Transferred from net profit to special reserve

 

-

-

-

-

13,145,012

-

-

-

-

(13,145,012)

-

-

-

-

-

Dividend paid

 

-

-

-

-

-

-

-

-

-

(8,993,602)

-

-

(8,993,602)

(289,028)

(9,282,630)

Cost of employee's stock ownership plan (ESOP)

 

-

-

-

-

-

-

-

-

-

-

1,262,609

-

1,262,609

-

1,262,609

Capital increase

3,347,781

-

(3,070,851)

-

-

-

-

-

-

-

-

-

276,930

-

276,930

Balance at the end of the year

33,779,361

8,979,958

79,110,551

1,577,092

13,145,012

(670,972)

25,064

1,996,573

15,296

83,254,686

2,343,532

842,029

224,398,182

27,876

224,426,058

 

Consolidated statement of changes in equity for the year ended December 31, 2024

 

Dec. 31, 2024

Issued and paid-up capital

Legal reserve

General reserve

General risk reserve

Special reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders' Equity

Non-controlling interests

Total

 

Beginning balance

30,195,010

4,770,354

39,840,707

1,550,906

-

(670,972)

21,155

(17,313,043)

15,230

27,442,585

1,486,010

148,353

87,486,295

160,073

87,646,368

Total comprehensive income net of tax:

 

Net profit of the year

 

-

-

-

-

-

-

-

-

-

49,558,744

-

-

49,558,744

60,338

49,619,082

Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI

 

-

-

-

-

-

-

-

(370,224)

-

-

-

-

(370,224)

-

(370,224)

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

-

-

8,956,422

-

-

-

-

8,956,422

-

8,956,422

Transferred (from) to banking risk reserve

 

-

-

-

-

-

-

-

-

2,694

(2,694)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

-

-

-

-

-

-

-

936,949

-

-

-

-

936,949

-

936,949

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

-

989,367

989,367

-

989,367

Total comprehensive income

-

-

-

-

-

-

-

9,523,147

2,694

49,556,050

-

989,367

60,071,258

60,338

60,131,596

Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI

-

-

-

-

-

-

-

-

-

370,224

-

-

370,224

-

370,224

Transferred to reserves

-

1,438,320

22,582,085

-

-

-

1,663

-

-

(23,398,943)

(623,125)

-

-

-

-

Dividend paid

-

-

-

-

-

-

-

-

-

(2,379,819)

-

-

(2,379,819)

(37,367)

(2,417,186)

Cost of employee's stock ownership plan (ESOP)

 

-

-

-

-

-

-

-

-

-

-

1,005,350

-

1,005,350

-

1,005,350

Capital increase

236,570

-

-

-

-

-

-

-

-

-

-

-

236,570

-

236,570

Balance at the end of the year

30,431,580

6,208,674

62,422,792

1,550,906

-

(670,972)

22,818

(7,789,896)

17,924

51,590,097

1,868,235

1,137,720

146,789,878

183,044

146,972,922

 

Consolidated Statement of Cash Flow for the Year Ended December 31, 2025

 

 

 

Notes

Dec. 31, 2025

 

Dec. 31, 2024

 

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

Profit before income tax

 

104,803,388

 

71,498,028

 

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

2,307,297

 

1,414,920

 

Impairment charge for credit losses (Loans and advances to customers)

(9,101,206)

 

4,768,107

 

Net charge/release for other provisions

(2,893,591)

 

3,363,525

 

Impairment release/charge for credit losses (due from banks)

137,399

 

(341)

 

Impairment release/charge for credit losses (financial investments)

146,649

 

(243,947)

 

Impairment release/charge for other assets

-

 

37,939

 

Exchange revaluation differences for financial assets at fair value through OCI and AC

5,137,808

 

(21,026,044)

 

Utilization of other provisions

(7,467)

 

(9,586)

 

Revaluation differences impairment charge for due from banks

(8,542)

 

2,008

 

Exchange revaluation differences of other provisions

(77,925)

 

4,173,699

 

Revaluation differences impairment charge for Financial Assets at Amortized cost

(18,527)

 

119,504

 

Profits from selling property, plant and equipment

(13,005)

 

(2,246)

 

Profits/losses from selling financial investments at fair value through OCI

(498,433)

 

(459,337)

 

Revaluation differences impairment charge for Financial Assets at Fair value through OCI

(242,624)

 

1,329,905

 

Shares based payments

1,262,609

 

1,005,350

 

Profits/losses from selling investments in associates

(277,408)

 

-

 

Net share of results of associates

(10,512)

 

17,786

 

 

 

100,645,910

 

65,989,270

 

 

 

 

 

Change in:

 

 

 

 

Due from banks

98,091,341

 

(111,192,809)

 

Financial assets at fair value through profit or loss

(2,792,770)

 

(74,394)

 

Derivative financial instruments

(88,654)

 

490,593

 

Loans and advances to banks and customers

(180,420,385)

 

(122,049,597)

 

Other assets

(5,289,420)

 

(22,078,200)

 

Non-current assets held for sale

(182,827)

 

-

 

Non-current liabilities held for sale

52,463

 

524

 

Due to banks

1,318,861

 

(10,423,118)

 

Due to customers

137,799,735

 

295,358,479

 

Current income tax obligations paid

(27,080,861)

 

(5,220,965)

 

Other liabilities

7,489,703

5,788,117

 

Net cash generated from operating activities

 

129,543,096

 

96,587,900

 

 

 

 

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from sale of investments in associates

339,920

 

11,956

 

Payments for purchases of property, equipment and branches construction

(7,930,273)

 

(6,707,018)

 

Proceeds from selling property and equipment

13,005

 

2,246

 

Proceeds from redemption of financial assets at amortized cost

21,689,390

 

2,028,180

 

Payments for purchases of financial assets at amortized cost

(90,488,312)

 

(129,153,136)

 

Payments for purchases of financial assets at fair value through OCI

(263,771,830)

 

(113,445,585)

 

Proceeds from selling financial assets at fair value through OCI

127,867,188

140,381,225

 

Net cash generated from (used in) investing activities

 

(212,280,912)

 

(106,882,132)

 

 

 

 

 

 

Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 (Cont.)

 

 

 

Notes

Dec. 31, 2025

 

Dec. 31, 2024

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Other loans

 

6,509,110

 

11,478,482

 

Other loans - new loans obtained in the year

8,701,546

3,835,016

 

Other loans - loans repaid in the year

(789,099)

(243,015)

 

Other loans - movement in foreign exchange rate

(1,403,337)

7,886,481

 

Dividends

(9,282,630)

 

(2,379,819)

 

Issued debt instruments

(306,223)

 

1,994,432

 

Cash payments for lease (principal and interest)

(391,907)

 

(501,724)

 

Capital increase

276,930

236,570

 

Net cash generated from (used in) financing activities

 

(3,194,720)

 

10,827,941

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the year

(85,932,536)

 

533,709

 

Beginning balance of cash and cash equivalent

226,475,092

225,941,383

 

Cash and cash equivalent at the end of the year

 

140,542,556

 

226,475,092

 

 

 

 

 

Cash and cash equivalent at the end of the year

 

 

 

 

Cash and cash equivalents

13

20,002,406

 

21,752,997

 

Due from banks with maturities of 3 months or less

15

120,525,563

 

203,103,430

 

Treasury bills and other governmental notes with maturities of three months or less

 

14,587

1,618,665

 

Total cash and cash equivalent

32

140,542,556

 

226,475,092

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR DBGDDXGGDGLC

Related Shares:

Com.int.bk.regs
FTSE 100 Latest
Value10,413.94
Change-153.71